FONTANA ESTEVEZ F; MIKSZTOWICZ V; IGNACIO M. SEROPIAN; PABLO CASSAGLIA; VANESSA TOUCEDA ; ROMINA BUSTOS; TOMAS CIANCIULLI; VERÓNICA CASSANOVA; CELINA MORALES; GERMÁN E. GONZÁLEZ

Experimental Model Of Myocardial Infarction For Studying The Role Of Galectin-3 On Wound Healing And Cardiac Remodeling In Mice

JoVe Journal; Año: 2023

MACRI EV; BOZZINI C; FERREIRA-MONTEIRO AG; RODRIGUEZ PN; LIFSHITZ F; MIKSZTOWICZ VJ; FRIEDMAN SM

Effect of fried sunflower oil intake on mandibular biomechanical competence of growing rats

Acta Odontologica Latinoamericana; Año: 2023

SEROPIAN IM; FONTANA ESTEVEZ FS; VILLAVERDE A; CACCIAGIÚ L; BUSTOS R; TOUCEDA V; PENAS F; SELSER C; MORALES C; MIKSZTOWICZ V; GONZÁLEZ GE

Galectin-3 contributes to acute cardiac dysfunction and toxicity by increasing oxidative stress and fibrosis in doxorubicin-treated mice

INTERNATIONAL JOURNAL OF CARDIOLOGY; Lugar: Amsterdam; Año: 2023

SEROPIAN, IGNACIO M.; CASSAGLIA, PABLO; MIKSZTOWICZ, VERÓNICA; GONZÁLEZ, GERMÁN E.

Unraveling the role of galectin-3 in cardiac pathology and physiology

Frontiers in Physiology; Año: 2023 vol. 14

BARCHUK M; ANCEL P; MIKSZTOWICZ V; DOUKBI E; SVILAR L, ; YÑÓN D; NOGUEIRA JP,; RUBIO M; SCHREIER L; DUTOUR A; MARTIN JC; GABORIT B; BERG G

Epicardial Adipose Tissue Ceramides Are Related to Lipoprotein Lipase Activity in Coronary Artery Disease: Unfolding a Missing Link.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY; Lugar: Philadelphia; Año: 2022

ESTEVEZ, FLORENCIA FONTANA; BETAZZA MC; MIKSZTOWICZ V; SEROPIAN I; SILVA M; PENAS F; TOUCEDA V; SELSER C; VILLAVERDE A; GOREN N; CIANCIULI T; MEDINA V; MORALES C; GIRONACCI M; GONZALEZ GE

Genetic deletion of Galectin-3 exacerbates age-related myocardial hypertrophy and fibrosis in mice

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY : INTERNATIONAL JOURNAL OF EXPERIMENTAL CELLULAR PHYSIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY.; Año: 2022 vol. 56 p. 353 - 366

FINOCCHIETTO, P; PEREZ, H; BLANCO, G; MIKSZTOWICZ, V; MAROTTE, C; MORALES, C; PERALTA, J; BERG, G; PODEROSO, C; PODEROSO, JJ; CARRERAS, MC

Inhibition of Mitochondrial Fission by Drp-1 Blockade by Short-Term Leptin and Mdivi-1 Treatment Improves White Adipose Tissue Abnormalities in Obesity and Diabetes

PHARMACOLOGICAL RESEARCH; Año: 2021

BARCHUK M; DUTOUR A; ANCEL P; SVILAR L; MIKSZTOWICZ V; LOPEZ G; RUBIO M; SCHREIER L; NOGUEIRA JP; VALÉRO R; BÉLIARD S; MARTIN JC; BERG G; GABORIT B

Untargeted Lipidomics Reveals a Specific Enrichment in Plasmalogens in Epicardial Adipose Tissue and a Specific Signature in Coronary Artery Disease

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY; Lugar: Philadelphia; Año: 2020

BARCHUK M; NAGASAWA T; MURAKAMI M; LÓPEZ G; BALDI J; MIKSZTOWICZ V; RUBIO M; SCHREIER L; NAKAJIMA K; BERG G

The antagonic behavior of GPIHBP1 between EAT and circulation does not reflect lipolytic enzymes levels in the tissue and serum from coronary patients

CLINICA CHIMICA ACTA; Lugar: Amsterdam; Año: 2020 vol. 510 p. 423 - 429

CASSAGLIA, PABLO; PENAS, FEDERICO; BETTAZZA, CELESTE; ESTEVEZ, FLORENCIA FONTANA; MIKSZTOWICZ, VERÓNICA; NAYA, NADIA MARTÍNEZ; LLAMOSAS, MARÍA CLARA; TRUANT, SOFÍA NOLI; WILENSKY, LUCIANA; VOLBERG, VERÓNICA; CEVEY, ÁGATA C.; TOUCEDA, VANESSA; CICALE, ELIANA; BERG, GABRIELA; FERNÁNDEZ, MARISA; GOREN, NORA; MORALES, CELINA; GONZÁLEZ, GERMÁN E.

Genetic Deletion of Galectin-3 Altered the Temporal Evolution of Macrophage Infiltration and Healing Affecting the Cardiac Remodeling and Function after Myocardial Infarction in Mice

AMERICAN JOURNAL OF PATHOLOGY; Año: 2020

BARCHUK M; SCHREIER L; LÓPEZ G; CEVEY A,; BALDI J; FERNANDEZ TOMÉ MDC; GOREN N; RUBIO M; MIKSZTOWICZ V; BERG G

Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 and angiopoietin-like protein 4 are associated with the increase of lipoprotein lipase activity in epicardial adipose tissue from diabetic patients.

ATHEROSCLEROSIS; Lugar: Amsterdam; Año: 2019 vol. 288 p. 51 - 59

BERG G; BARCHUK M; MIKSZTOWICZ, VERÓNICA

Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling

Cells; Año: 2019

BARCHUK M; TOUCEDA V,; BERMEJO F; LÓPEZ G; RUBIO M; MIKSZTOWICZ V; SCHREIER L; BERG G

Rol de ANGPTL4, GPIHBP1 y PPARγ como moduladores del comportamiento de LPL en el tejido adiposo epicárdico de pacientes con enfermedad coronaria

Revista Argentina de Lipidos; Año: 2019 vol. 3 p. 66 - 77

BARCHUK, MAGALÍ; MIKSZTOWICZ, VERÓNICA; ZAGO, VALERIA; CEVEY, AGATA; LÓPEZ, GRACIELA; GOREN, NORA; FRIEDMAN, SILVIA; GELPI, RICARDO JORGE; MORALES, CELINA; FERNANDEZ TOMÉ, MARÍA DEL CARMEN; SCHREIER, LAURA; BERG, GABRIELA

Endothelial Lipase Is an Alternative Pathway for Fatty Acid Release from Lipoproteins: Evidence from a High Fat Diet Model of Obesity in Rats

LIPIDS; Año: 2018 vol. 53 p. 993 - 1003

BARCHUK M; SCHREIER L; BERG G; MIKSZTOWICZ V

Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis.

Hormone Molecular Biology and Clinical Investigation; Año: 2018

LUCERO D; MIKSZTOWICZ V; GUALANO G; LONGO C; LANDEIRA G; ALVAREZ E; ZAGO V ; BRITES F ; BERG G; FASSIO E; SCHREIER L

Nonalcoholic fatty liver disease associated with metabolic syndrome. Influence of liver fibrosis stages on characteristics of very low density lipoproteins.

CLINICA CHIMICA ACTA; Lugar: Amsterdam; Año: 2017 vol. 473 p. 1 - 8

MIKSZTOWICZ V; MORALES C; BARCHUK M; LÓPEZ GI; PÓVEDA R; GELPI R; SCHREIER L; RUBIO M; BERG G

Metalloproteinase 2 and 9 Activity Increase in Epicardial Adipose Tissue of Patients with Coronary Artery Disease

CURRENT VASCULAR PHARMACOLOGY; Lugar: Oak Park; Año: 2017 vol. 15 p. 135 - 143

BRENTA G; BERG G; MIKSZTOWICZ V; LOPEZ G; LUCERO D; FAINGOLD C; MURAKAMI M; MACHIMA T; NAKAJIMA K; SCHREIER L

Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine

THYROID; Lugar: New York; Año: 2016 vol. 26 p. 365 - 372

GAGLIARDI JA ; MACIEL N; CASTELLANO JL; MASOLI O; MIKSZTOWICZ V; BERG G; BERMEJO E; LAZZARI M; GELPI RJ

Relationship between endothelial progenitor cells and vascular endothelial growth factor and its variation with exercise

THROMBOSIS RESEARCH; Lugar: Amsterdam; Año: 2016 vol. 137 p. 92 - 96

LUCERO D; MIKSZTOWICZ V; CACCIAGIÚ L; LÓPEZ G; FERNÁNDEZ MACHULSKY N; BERG G; ZAGO V; SCHREIER L

Adiponectina determinaría el predominio de VLDL alteradas en el síndrome metabólico.

ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Lugar: La Plata; Año: 2016 vol. 50 p. 575 - 581

FERNANDEZ MACHULSKY N; GAGLIARDI J; FABRE B; MIKSZTOWICZ V; LOMBARDO M; GARCIA ESCUDERO A; GIGENA G; BLANCO F; GELPI RJ; SCHREIER L; GIDRON Y; BERG G

Matrix metalloproteinases and psychosocial factors in acute coronary syndrome patients

PSYCHONEUROENDOCRINOLOGY; Lugar: Amsterdam; Año: 2016 vol. 63 p. 102 - 108

LUCERO D; MIKSZTOWICZ V; MACRI EV; LOPEZ GH; FRIEDMAN S; BERG G; ZAGO V; SCHREIER L

Over-production of altered VLDL in an insulin-resistance rat model: influence of SREBP-1c and PPAR-α

Clínica e Investigación en Areteriosclerosis; Año: 2015 vol. 27 p. 167 - 174

GAGLIARDI J; NEIVA M; CASTELLANO JL; MIKSZTOWICZ V; BERG G; GELPI RJ

Variaciones de los Niveles Plasmáticos de VEGF con el Ejercicio en Pacientes con Enfermedad Coronaria Crónica

REVISTA ARGENTINA DE CARDIOLOGIA; Año: 2015 vol. 83 p. 233 - 236

BERG G; MIKSZTOWICZ V

Metalloproteinases in the pathogenesis and progression of metabolic syndrome: potential targets for improved outcomes

J Metalloproteinases in Medicine; Año: 2015 vol. 2 p. 51 - 59

MIKSZTOWICZ V; MORALES C; ZAGO V; FRIEDMAN S; SCHREIER L; BERG G

Effect of insulin-resistance on circulating and adipose tissue MMP-2 and MMP-9 activity in rats fed a sucrose-rich diet.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES; Lugar: Amsterdam; Año: 2014 vol. 24 p. 294 - 300

MIKSZTOWICZ V; SCHREIER L; MCCOY M; LUCERO D; FASSIO E; BILLHEIMER J; RADER DJ; BERG G

Role of SN1 Lipases on Plasma Lipids in Metabolic Syndrome and Obesity.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY; Lugar: Philadelphia; Año: 2014 vol. 34 p. 669 - 675

BERG G; SCHREIER L; MIKSZTOWICZ V

Circulating and adipose tissue matrix metalloproteinases in cardiometabolic risk environments: Pathophysiological aspects.

Hormone Molecular Biology and Clinical Investigation; Año: 2014

MIKSZTOWICZ V ; FERNANDEZ MACHULSKY N; LUCERO D; FASSIO E; SCHREIER L; BERG G

Adiponectin predicts MMP-2 activity independently of obesity.

Eur J Clin Invest; Año: 2014 vol. 44 p. 951 - 957

BUCHHOLZ B; PEREZ V; SIACHOQUE N; MIKSZTOWICZ VERONICA; BERG G; RODRÍGUEZ M; DONATO M; GELPI RJ

Dystrophin proteolysis: a potential target for MMP-2 and its prevention by ischemic preconditioning

Am J Physiol Heart Circ Physiol; Año: 2014 vol. 307 p. 88 - 96

ZAGO V; MIKSZTOWICZ V; CACCIAGIÚ L; BASILIO F; BERG G; SCHREIER L

High density lipoprotein is an inappropiate substrate for hepatic lipase in postmenopausal women

CLINICA CHIMICA ACTA; Lugar: Amsterdam; Año: 2012 vol. 414 p. 142 - 145

MIKSZTOWICZ VERONICA; MCCOY MG; SCHREIER L; CACCIAGIÚ L; ELBERT A; GONZALEZ A; BILLHEIMER J; EACHO PI; RADER DJ; BERG G

Endothelial Lipase Activity Predicts High-Density Lipoprotein Catabolism in Hemodialysis : Novel Phospholipase Assay in Postheparin Human Plasma

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY; Lugar: Philadelphia; Año: 2012 vol. 32 p. 3033 - 3040

MIKSZTOWICZ V ; LUCERO D; ZAGO V; CACCIAGIÚ L; LOPEZ G; GONZALEZ BALLERGA E; SORDÁ J; FASSIO E; SCHREIER L; BERG G

Hepatic lipase activity is increased in non- alcoholic fatty liver disease beyond insulin resistance

DIABETES/METABOLISM RESEARCH AND REVIEWS.; Lugar: Londres; Año: 2012 vol. 28 p. 535 - 541

MUZZIO ML ,MIKSZTOWICZ V; REPETTO EM; BRITES F; BERG G; SCHREIER L

Increased MMP-2 in healthy postmenopausal women

ANNALS OF CLINICAL BIOCHEMISTRY; Año: 2012 vol. 49 p. 75 - 79

MIKSZTOWICZ V; SISELES N; FERNANDEZ MACHULSKY N; SCHREIER L; BERG G

Increase in MMP-2 activity in overweight and obese women is associated with the menopausal status

CLIMACTERIC; Lugar: Londres; Año: 2012 vol. 15 p. 602 - 606

D´ANNUNZIO V; DONATO M; BUCHHOLZ B; PÉREZ V; MIKSZTOWICZ V; BERG G; GELPI RJ

High-cholesterol diet effects on ischemia/reperfusion injury of the heart

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY; Lugar: Otawa; Año: 2012 vol. 90 p. 1185 - 1196

MUSSO C; GRAFFIGNA M; SOUTELO J; HONFI M; LEDESMA L; MIKSZTOWICZ V; PASOS M; MIGLIANO M; SCHREIER L; BERG G

Cardiometabolic risk factors as apolipoprotein b, triglycerides/hdl-cholesterol ratio and c-reactive protein, in adolescents with and without obesity.

PEDIATRIC DIABETES; Año: 2011 vol. 12 p. 229 - 234

BERG G; MIKSZTOWICZ V; SCHREIER L

Metalloproteinases in metabolic syndrome

CLINICA CHIMICA ACTA; Lugar: Amsterdam; Año: 2011 vol. 412 p. 1731 - 1739

LUCERO D; ZAGO V; LOPEZ GI; GRAFFIGNA M; LOPEZ GH; FAINBOIM H; MIKSZTOWICZ V; GÓMEZ ROSSO L; BELLI S; LEVALLE O; WIKINSKI R; BERG G; BRITES F; SCHREIER L

Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?

CLINICA CHIMICA ACTA; Lugar: Amsterdam; Año: 2011 vol. 412 p. 587 - 592

LUCERO D; ZAGO V; LÓPEZ GI; GRAFFIGNA M; FAINBOIM H; MIKSZTOWICZ V; MEROÑO T; BELLI S; LEVALLE O; WIKINSKI R; BRITES F; BERG G; SCHREIER L

Pro-inflammatory and Atherogenic Circulating Factors in Non Alcoholic Fatty Liver Disease Associated to Metabolic Syndrome.

CLINICA CHIMICA ACTA; Lugar: Amsterdam; Año: 2011 vol. 412 p. 143 - 147

ZAGO V; LUCERO D; MACRI EV; CACCIAGIÚ L; GAMBA CA; MIKSZTOWICZ V; BERG G; WIKINSKI R; FRIEDMAN S; SCHREIER L

Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model

ANNALS OF NUTRITION AND METABOLISM; Año: 2010 vol. 53 p. 198 - 206

DONATO M; D ANNUNZIO V; BUCHHOLZ B; MIKSZTOWICZ V; LORENZO CARRIÓN C; VALDEZ LB; ZAOBORNYJ T; SCHREIER L; WIKINSKI R; BOVERIS A; BERG G; GELPI RJ

Role of matrix metalloproteinase-2 in the cardioprotective effect of ischemic postconditioning.

EXPERIMENTAL PHYSIOLOGY.; Año: 2010 vol. 95 p. 274 - 281

MUZZIO ML; MIKSZTOWICZ V; BRITES F; AGUILAR D; REPETTO EM; TAVELLA M; WIKINSKI R; SCHREIER L; BERG G

Metalloproteases 2 and 9, Lipoprotein-associated phospholipase-A2 and lipoprotein profile in coronary patients

ARCHIVES OF MEDICAL RESEARCH (ELETRONICO); Año: 2009 vol. 40 p. 48 - 53

DONATO M; ERNI L; MIKSZTOWICZ V; BUCHHOLZ B; LORENZO CARRIÓN C; SCHREIER L; WIKINSKI R; GELPI RJ; BERG G; BASSO N

Rosuvastatin given during reperfusion decreases infarct size and inhibits MMP-2 activity in normo and Hypercholesterolemic rabbits

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; Año: 2009 vol. 53 p. 137 - 144

LORENZO CARRIÓN C; MIKSZTOWICZ V; ERNI L; BUCHHOLZ B; D'ANNUNZIO V; BERG G; SCHREIER L; WIKINSKI R; BASSO N

Efecto de la rosuvastatina sobre el infarto experimental en conejos normales e hipercolesterolémicos

Revista Argentina de Cardiología; Año: 2008 vol. 76 p. 118 - 122

MIKSZTOWICZ V; MUZZIO ML; ROYER M; PRADA M; WIKINSKI R; SCHREIER L; BERG G

Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome

METABOLISM-CLINICAL AND EXPERIMENTAL; Año: 2008 vol. 57 p. 1493 - 1496

BERG G; BRITES F; MUZZIO ML; ZAGO V; LOPEZ G; BENITEZ MB; GOMEZ ROSSO L; MIKSZTOWICZ V; CACCIAGIÚ L; GONZALEZ A; AISEMBERG L; SCHREIER L; WIKINSKI R

Factores circulantes de injuria endotelial y procesos subendoteliales en mujeres postmenopáusicas sanas

ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Año: 2007 vol. 41 p. 499 - 510

BERSIER MG; MIKSZTOWICZ V; PENA C; RODRIGUEZ DE LORES ARNAIZ G

Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+- ATPase inhibitor

NEUROCHEMICAL RESEARCH; Año: 2005 vol. 30 p. 479 - 486